Key points are not available for this paper at this time.
As noted in this Editor’s Page previously, the rising cost of developing new cardiovascular therapies cannot be sustained in the long-term (1)1. Accordingly, there is a critical need for new methodologies that can improve the speed, efficiency, and success rate of efforts to develop new
Foraker et al. (Mon,) studied this question.